Intelligent Antibody Discovery


Kirby Alton, PhD – Executive Chairman

Kirby was one of the original Amgen scientists (1981) and from 1983 through his retirement in 1999 was head of Amgen product development serving as Senior VP of Development. During this time, Amgen discovered and brought its first products to market, Epogen and Neupogen. Dr. Alton had responsibility for global Pre-clinical and Clinical Research and Regulatory Affairs, serving as the company’s Responsible Head and the Executive Operating Committee.

Richard Shimkets, PhD- President and CEO

Rick serves as the President and CEO of Abeome Corporation.  Prior to joining Abeome, he served as Vice President of Drug Discovery and Vice President of Scientific Development for CuraGen Corporation. He developed and managed partnerships with Genentech, Biogen, Bayer, and other biotechnology and pharmaceutical companies.